150 related articles for article (PubMed ID: 30924126)
41. Effects of allopurinol on striatal dopamine, ascorbate and uric acid during an acute morphine challenge: ex vivo and in vivo studies.
Enrico P; Esposito G; Mura MA; Migheli R; Serra PA; Desole MS; Miele E; De Natale G; Miele M
Pharmacol Res; 1997 Jun; 35(6):577-85. PubMed ID: 9356212
[TBL] [Abstract][Full Text] [Related]
42. Allopurinol inhibits uric acid accumulation in the rat brain following focal cerebral ischemia.
Kanemitsu H; Tamura A; Kirino T; Oka H; Sano K; Iwamoto T; Yoshiura M; Iriyama K
Brain Res; 1989 Oct; 499(2):367-70. PubMed ID: 2804684
[TBL] [Abstract][Full Text] [Related]
43. Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.
Day RO; Miners JO; Birkett DJ; Whitehead A; Naidoo D; Hayes J; Savdie E
Br J Clin Pharmacol; 1988 Oct; 26(4):423-8. PubMed ID: 3190992
[TBL] [Abstract][Full Text] [Related]
44. Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate.
van der Pol KH; Nijenhuis M; Soree B; de Boer-Veger NJ; Buunk AM; Guchelaar HJ; Risselada A; van Schaik RHN; Swen JJ; Touw D; van der Weide J; van Westrhenen R; Deneer VHM; Houwink EJF; Rongen GA
Eur J Hum Genet; 2024 Feb; 32(2):155-162. PubMed ID: 36056234
[TBL] [Abstract][Full Text] [Related]
45. Neoadjuvant Endocrine Therapy in Breast Cancer Upregulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy.
Baxter DE; Kim B; Hanby AM; Verghese ET; Sims AH; Hughes TA
Clin Breast Cancer; 2018 Dec; 18(6):481-488. PubMed ID: 30055962
[TBL] [Abstract][Full Text] [Related]
46. The pharmacokinetics or oral and intravenous allopurinol and intravenous oxypurinol in the horse.
Mills PC; Dunnett M; Smith NC
J Vet Pharmacol Ther; 1995 Dec; 18(6):451-6. PubMed ID: 8789699
[TBL] [Abstract][Full Text] [Related]
47. An audit of a therapeutic drug monitoring service for allopurinol therapy.
Kannangara DR; Ramasamy SN; Ray JE; Jones G; Graham GG; Williams KM; Day RO
Ther Drug Monit; 2013 Dec; 35(6):863-6. PubMed ID: 24263644
[TBL] [Abstract][Full Text] [Related]
48. Deferoxamine, allopurinol and oxypurinol are not neuroprotective after oxygen/glucose deprivation in an organotypic hippocampal model, lacking functional endothelial cells.
Peeters C; Hoelen D; Groenendaal F; van Bel F; Bär D
Brain Res; 2003 Feb; 963(1-2):72-80. PubMed ID: 12560112
[TBL] [Abstract][Full Text] [Related]
49. Effects of bovine milk ingestion on urinary excretion of oxypurinol and uric acid.
Kurajoh M; Ka T; Okuda C; Yamamoto A; Tsutsumi Z; Koyama H; Moriwaki Y; Yamamoto T
Int J Clin Pharmacol Ther; 2011 Jun; 49(6):366-70. PubMed ID: 21612743
[TBL] [Abstract][Full Text] [Related]
50. A new sensitive and quantitative chemiluminescent assay to monitor intracellular xanthine oxidase activity for rapid screening of inhibitors in living endothelial cells.
Caliceti C; Calabria D; Roda A
Anal Bioanal Chem; 2016 Dec; 408(30):8755-8760. PubMed ID: 27392750
[TBL] [Abstract][Full Text] [Related]
51. The transport of uric acid across mouse small intestine in vitro.
Bronk JR; Shaw MI
J Physiol; 1986 Sep; 378():229-39. PubMed ID: 3795104
[TBL] [Abstract][Full Text] [Related]
52. The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.
Stiburkova B; Pavelcova K; Pavlikova M; Ješina P; Pavelka K
Arthritis Res Ther; 2019 Mar; 21(1):77. PubMed ID: 30894219
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia.
Springer J; Tschirner A; Hartman K; Palus S; Wirth EK; Ruis SB; Möller N; von Haehling S; Argiles JM; Köhrle J; Adams V; Anker SD; Doehner W
Int J Cancer; 2012 Nov; 131(9):2187-96. PubMed ID: 22336965
[TBL] [Abstract][Full Text] [Related]
54. Oxipurinol: alloxanthine, Oxyprim, oxypurinol.
Drugs R D; 2004; 5(3):171-5. PubMed ID: 15139781
[TBL] [Abstract][Full Text] [Related]
55. Free radical scavenging and antioxidant activity of allopurinol and oxypurinol in experimental lens-induced uveitis.
Augustin AJ; Böker T; Blumenröder SH; Lutz J; Spitznas M
Invest Ophthalmol Vis Sci; 1994 Oct; 35(11):3897-904. PubMed ID: 7928187
[TBL] [Abstract][Full Text] [Related]
56. Genetic background of uric acid metabolism in a patient with severe chronic tophaceous gout.
Petru L; Pavelcova K; Sebesta I; Stiburkova B
Clin Chim Acta; 2016 Sep; 460():46-9. PubMed ID: 27288985
[TBL] [Abstract][Full Text] [Related]
57. Effect of lactate infusion on renal transport of purine bases and oxypurinol.
Yamamoto T; Moriwaki Y; Takahashi S; Nasako Y; Higashino K
Nephron; 1993; 65(1):73-6. PubMed ID: 8413795
[TBL] [Abstract][Full Text] [Related]
58. The pharmacokinetics of injectable allopurinol in newborns with the hypoplastic left heart syndrome.
McGaurn SP; Davis LE; Krawczeniuk MM; Murphy JD; Jacobs ML; Norwood WI; Clancy RR
Pediatrics; 1994 Dec; 94(6 Pt 1):820-3. PubMed ID: 7970996
[TBL] [Abstract][Full Text] [Related]
59. IL-1β functionally attenuates ABCG2 and PDZK1 expression in HK-2 cells partially through NF-ĸB activation.
Lu X; Chen M; Shen J; Xu Y; Wu H
Cell Biol Int; 2019 Mar; 43(3):279-289. PubMed ID: 30632646
[TBL] [Abstract][Full Text] [Related]
60. Allopurinol hypersensitivity syndrome: hypersensitivity to oxypurinol but not allopurinol.
Hamanaka H; Mizutani H; Nouchi N; Shimizu Y; Shimizu M
Clin Exp Dermatol; 1998 Jan; 23(1):32-4. PubMed ID: 9667107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
